Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2003
03/13/2003WO2001096598A3 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF
03/13/2003WO2001082911A3 TREATMENT OF PATHOLOGICAL CONDITIONS INFLUENCED BY THE ACTION OF MATRIX METALLOPROTEINASES (MMPs) USING CLIOQUINOL
03/13/2003WO2001073032A3 Compositions and methods for the therapy and diagnosis of prostate cancer
03/13/2003US20030050345 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative
03/13/2003US20030050343 Novel potentiating compounds
03/13/2003US20030050341 Vitamin/Mineral Compositions with DHA
03/13/2003US20030050329 Synergistic combination comprising roflumilast and a PDE-3 inhibitor
03/13/2003US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity
03/13/2003US20030050307 Treating certain psychiatric and neurological disorders; anxiety disorder, panic disorder, obsessive compulsive disorder, depression, social phobia and eating disorders, and psychosis
03/13/2003US20030050305 Thromboxane inhibitors, compositions and methods of use
03/13/2003US20030050301 A drug mixture additionally comprising an antihypertensive agent or it's prodrug and a carrier, vehicle or diluent
03/13/2003US20030050297 Administering to a mammal, a low molecular weight antioxidants, mimetics of superoxide dismutase
03/13/2003US20030050290 Combination of formoterol and mometasone furoate for asthma
03/13/2003US20030050288 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; oral contraception using multiphase progestotational agents, antiprogestins, indole or thiophene derivatives and placebo
03/13/2003US20030050287 Mixture of 2-hydroxyestrone and a substantially less amount of 17-beta estradiol
03/13/2003US20030050283 Composition for the treatment and/or prevention of macular degeneration, method for its manufacture, and its use for treating the eye
03/13/2003US20030050272 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides
03/13/2003US20030050271 Infecting the vasculature of an organ or a tissue other than a liver with a vector carrying genetic material of interest for a time under conditions which protect from ischemic damage
03/13/2003US20030050268 Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
03/13/2003US20030050262 Inhibition of neurodegeneration
03/13/2003US20030050261 Immunostimulatory nucleic acid molecules
03/13/2003US20030050253 The synergistic combination of a loop diuretic and a cardiac glycoside is useful in the treatment of DNA viral infections such as Herpes virus infections
03/13/2003US20030050249 Complexes of alpha-6 integrin subunits with small peptides and methods for treating indications resulting from modulation of integrin-mediated responses by altering signal transduction
03/13/2003US20030050235 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
03/13/2003US20030049790 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049699 Polypeptide for use in the treatment of cell proliferation disorders
03/13/2003US20030049697 Detection of potassium channel modulators for treatment of heart, vascular and endrocrine pathologies; obtain sample, incubate with modulator, monitor effect of modulator on transport protein activity
03/13/2003US20030049672 Modulation of protein binding; obtain sample containing polypeptides, incubate with modulator, detect adjustment in protein activity
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003US20030049617 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
03/13/2003US20030049331 Mixture of loop diuretics and lithium; contact lenses
03/13/2003US20030049314 Mixture of anticholesterol agent, enzyme inhibitor and aspirin
03/13/2003US20030049308 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication
03/13/2003US20030049287 Catechol oximes and their use in cosmetic and dermatological preparations
03/13/2003US20030049281 Topical emulsion; quaternary ammonium salt emulsifier
03/13/2003US20030049262 Methods for identification, diagnosis, and treatment of breast cancer
03/13/2003US20030049260 Method of improving cognitive function
03/13/2003US20030049258 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/13/2003US20030049255 Interleukin-1 receptors in the treatment of diseases
03/13/2003US20030049252 Controlling immunology response; autoimmune disease, antiallergens
03/13/2003US20030049227 Antitumor, anticarcinogenic agents; using fusion protein
03/13/2003US20030049226 Methods of treating syndrome x with aliphatic polyamines
03/13/2003US20030049211 Remedies and preventives for dental diseases
03/13/2003US20030049205 That undergoes/interferes with cytochrome P450 metabolism, using d-threo-methylphenidate; side effect reduction of drug-drug interaction toxicity; tricyclic antidepressants or selective serotonin reuptake inhibitors
03/13/2003US20030049203 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2483959A1 Method for treating alzheimer's disease using quinaldoyl-amine derivatives of oxo- and hydroxy-substituted hydrocarbons
03/13/2003CA2459822A1 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
03/13/2003CA2459728A1 Late gestation lung genes, fragments and uses thereof
03/13/2003CA2459584A1 Compositions and use thereof in the treatment of cancer
03/13/2003CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003CA2459346A1 Benzothiazepine derivatives
03/13/2003CA2459161A1 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/13/2003CA2459146A1 Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
03/13/2003CA2459136A1 A caspase-8 binding protein, its preparation and use
03/13/2003CA2459045A1 Antidiabetic extracts of artemisia dracunculus
03/13/2003CA2459017A1 Medicinal compositions containing angiotensin ii receptor antagonist
03/13/2003CA2458993A1 A method for the treatment or prevention of bone erosion
03/13/2003CA2458968A1 Method for classification of anti-psychotic drugs
03/13/2003CA2458926A1 Methods of treating infection by drug resistant bacteria
03/13/2003CA2458807A1 Use of atazanavir in hiv therapy
03/13/2003CA2458805A1 Potentiator composition comprising a terpene for enhancing a therapeutical effect of antitumoral agents in the treatment of cancer
03/13/2003CA2458798A1 Method for reducing hypertension and heart failure
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2458670A1 Bv8 nucleic acids and polypeptides with mitogenic activity
03/13/2003CA2458523A1 C2-disubstituted indane-1-ol systems, method for their production and their use as medicaments
03/13/2003CA2458459A1 Anti-cancer combinations
03/13/2003CA2458348A1 Compositions for the treatment of parkinson's disease containing a cb1 receptor antagonist and a product that activates dopaminergic neurotransmission in the brain
03/13/2003CA2457861A1 Piperidine derivatives useful as ccr5 antagonists
03/13/2003CA2456904A1 Aerosolized decongestants for the treatment of sinusitis
03/13/2003CA2455896A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma
03/12/2003EP1291437A1 New assay for inhibitors of translocases
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291345A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/12/2003EP1291340A1 Phytosphingosine derivatives with antitumor activity
03/12/2003EP1291013A2 Storage-stable pharmaceutical compositions
03/12/2003EP1290451A2 Diagnosis of alzheimer's disease using ldl receptor protein-1
03/12/2003EP1290449A1 Use of the g protein coupled receptor gpr3 to identify apetite control agents
03/12/2003EP1290231A1 Two-hybrid assay that detects hiv-1 reverse transcriptase dimerization
03/12/2003EP1290227A1 Compositions, kits, and methods for identification and modulation of type i diabetes
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290191A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/12/2003EP1290188A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290185A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290182A1 Sphingosine kinase and uses thereof
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290174A2 G-protein coupled receptor org3.
03/12/2003EP1290168A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/12/2003EP1290167A1 Human kcnq5 potassium channel, methods and compositions thereof
03/12/2003EP1290166A1 Mutation in the beta 2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
03/12/2003EP1290153A2 Molecular delivery vehicle for delivery of selected compounds to targets
03/12/2003EP1290152A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290148A2 AMINOACYL tRNA SYNTHETASES
03/12/2003EP1290140A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof
03/12/2003EP1290033A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
03/12/2003EP1290029A2 Compositions comprising net-4 modulators and their use for treating neoplastic disease
03/12/2003EP1290023A2 Nuclear factor kb inducing factor
03/12/2003EP1290020A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors
1 ... 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 ... 1151